Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals
Summary GlobalData’s "Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry.The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2018.
The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
Scope - Analysis of the market trends for the pharmaceutical industry in the global arena. - Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments. - Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry. - Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As. - Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry. - Analysis of partnership and licensing deals based on clinical stage of development of products. - Summary of the pharmaceutical deals globally in the five years. - Information on the top deals happened in the pharmaceutical industry. - Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. - League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy - Enhance your decision making capability in a more rapid and time sensitive manner. - Find out the major deal performing segments for investments in your industry. - Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets. - Identify companies that are aggressively looking to raise capital in the market - Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry. - Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies. - Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry. - Identify growth segments and opportunities in each region within the industry. - Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Automated Liquid Handling Systems Market 2022-2026 The analyst has been monitoring the automated liquid handling systems market and it is poised to grow by $ 768.06 mn during 2022-2026, accelerating at a CAGR of 12.23% during the forecast period. Our report on the automated liquid handling systems market provides...
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Breast Enhancement Products Market 2022-2026 The analyst has been monitoring the breast enhancement products market and it is poised to grow by $ 68.66 mn during 2022-2026 progressing at a CAGR of 4.17% during the forecast period. Our report on the breast enhancement products market provides a holistic analysis,...
The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology...
The global hydrogel market reached a value of US$ 24.7 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 36 Billion by 2027, exhibiting a CAGR of 6.00% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 22.214.171.124) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase...
Bronchopulmonary Dysplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia - Drugs In Development, 2022, provides an overview of the Bronchopulmonary Dysplasia...
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 126.96.36.199) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Tyrosine Protein Kinase...
Vietnam Pharmaceuticals Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region,...
215 pages •
By Global Industry Analysts
• Feb 2022
Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...
353 pages •
By The Business Research Company
• Feb 2022
Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists; marketers and senior management with the critical information they need to assess the global hematology drugs market as it emerges from the COVID 19 shut down. Description: Where is the largest...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.